Unmasking Beta-Lactam Allergies in Children: A Closer Look at Diagnosis and Risk Factors
International Archives of Allergy and Immunology · 2025
DOI: 10.1159/000547369 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2025. Verfasst von Zeynep Meric und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Istanbul, Turkey. Hauptthemen laut MEDLINE: Drug Hypersensitivity, beta-Lactams, Anti-Bacterial Agents. Die Arbeit nennt 34 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Beta-lactam (BL) antibiotics are the most commonly implicated drugs in pediatric drug hypersensitivity reactions. However, most children with suspected BL allergy can safely tolerate these antibiotics after careful evaluation. The aim of this study was to evaluate the clinical characteristics, diagnostic work-up results, and risk factors associated with confirmed BL allergy in children referred with suspected BL hypersensitivity.
Methods
We retrospectively analyzed 158 children referred for suspected BL allergy between 2019 and 2025. Clinical and demographic data were collected from medical records. Diagnostic evaluation included skin testing and drug provocation testing. Patients were divided into two groups: those with confirmed BL allergy and those whose allergy label had been removed. Risk factors for BL allergy were compared between groups.
Results
The cohort included 158 children (58% male; median age: 100.5 months; interquartile range [IQR]: 75–150.75). The median time from reaction to clinical evaluation was 7 months (IQR: 3–25). The most commonly implicated drug was amoxicillin/clavulanate (81.5%). Immediate reactions (IR) occurred in 47.8% of cases. BL allergy was confirmed in 36.7% of the cases. In the final logistic regression model, the type of hypersensitivity reaction (p = 0.001), severity of reaction (p = 0.001), and the presence of comorbidities (p = 0.008) remained significant predictors of confirmed drug allergy.
Conclusion
Given the low true allergy rate, accurate diagnosis and delabeling of suspected BL allergy in children is essential to avoid unnecessary antibiotic restriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Istanbul, Turkey.
- Department of Pediatrics, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Istanbul, Turkey.
- Department of Pediatric Allergy and Immunology, University of Health Sciences, Bagcilar Research and Training Hospital, Istanbul, Turkey.
- Department of Pediatric Allergy and Immunology, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
- Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Istanbul, Turkey, dr_gora@yahoo.com.
Zitieren
APA
Meric, Z., Karaaslan, B. G., Aydemir, S., Aydin, M., Demir Gumus, D., Ozyildirim Demirel, S., Bulbul, L., Mustu, U., Cokugras, H., Celiksoy, M. H., Yucel, E., & Kiykim, A. (2025). Unmasking Beta-Lactam Allergies in Children: A Closer Look at Diagnosis and Risk Factors. International Archives of Allergy and Immunology. https://doi.org/10.1159/000547369
Vancouver
Meric Z, Karaaslan BG, Aydemir S, Aydin M, Demir Gumus D, Ozyildirim Demirel S, et al. Unmasking Beta-Lactam Allergies in Children: A Closer Look at Diagnosis and Risk Factors. International Archives of Allergy and Immunology. 2025. doi:10.1159/000547369
BibTeX
@article{Meric2025,
author = {Meric, Zeynep and Karaaslan, Betul Gemici and Aydemir, Sezin and Aydin, Muhammed and Demir Gumus, Dilan and Ozyildirim Demirel, Sevval and Bulbul, Lida and Mustu, Ulviye and Cokugras, Haluk and Celiksoy, Mehmet Halil and Yucel, Esra and Kiykim, Ayca},
title = {Unmasking Beta-Lactam Allergies in Children: A Closer Look at Diagnosis and Risk Factors},
journal = {International Archives of Allergy and Immunology},
year = {2025},
doi = {10.1159/000547369}
}
EUVIMED